Bellevue Life Sciences Acquisition (OSRH) Income Statement (2022 - 2026)
Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Bellevue Life Sciences Acquisition (OSRH).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||
Total Revenue | 480K (+26.32%) | 380K (-39.68%) | 630K (-44.74%) | 1.14M (+50.00%) | 760K (-17.39%) | 920K (+12.20%) | 820K (-6.82%) | 880K (-3.30%) | 910K | - | - | - | - | - | - | - | - |
Cost Of Revenue | 320K (+28.00%) | 250K (-32.43%) | 370K (-66.36%) | 1.10M (+86.44%) | 590K (-22.37%) | 760K (+18.75%) | 640K (-1.54%) | 650K (-2.99%) | 670K | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 320K (+28.00%) | 250K (-32.43%) | 370K (-66.36%) | 1.10M (+86.44%) | 590K (-22.37%) | 760K (+18.75%) | 640K (-1.54%) | 650K (-2.99%) | 670K | - | - | - | - | - | - | - | - |
Gross Profit | 160K (+23.08%) | 130K (-50.00%) | 260K (+766.67%) | 30K (-82.35%) | 170K (+6.25%) | 160K (-11.11%) | 180K (-21.74%) | 230K (-4.17%) | 240K | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||
Research And Development | 110K (-52.17%) | 230K | - | - | 90K (-18.18%) | 110K | - | - | 50K | - | - | - | - | - | - | - | - |
Selling General And Administrative | 3.83M (-41.26%) | 6.52M (+60.20%) | 4.07M (-22.62%) | 5.26M (+70.23%) | 3.09M (+74.58%) | 1.77M (-52.80%) | 3.75M (+9.01%) | 3.44M (-2.82%) | 3.54M (+311.63%) | 860K (+109.76%) | 410K (+46.43%) | 280K (0.00%) | 280K (+2700.00%) | 10K (-50.00%) | 20K | - | - |
Operating Expenses | 3.94M (-41.54%) | 6.74M (+65.60%) | 4.07M (-22.62%) | 5.26M (+65.41%) | 3.18M (+68.25%) | 1.89M (-49.60%) | 3.75M (+9.01%) | 3.44M (-4.18%) | 3.59M (+317.44%) | 860K (+109.76%) | 410K (+46.43%) | 280K (0.00%) | 280K (+2700.00%) | 10K (-50.00%) | 20K | - | - |
Depreciation And Amortization | 10K (0.00%) | 10K | - | - | - | -10.00K | - | - | 20K | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||
Operating Income | -3.67M (-42.57%) | -6.39M (+68.16%) | -3.80M (-27.34%) | -5.23M (+79.11%) | -2.92M (+81.37%) | -1.61M (-54.90%) | -3.57M (+11.21%) | -3.21M (-2.73%) | -3.30M (+80.33%) | -1.83M | - | - | - | -40.00K | - | - | - |
Ebit | -3.67M (-42.57%) | -6.39M (+68.16%) | -3.80M (-27.34%) | -5.23M (+79.11%) | -2.92M (+81.37%) | -1.61M (-54.90%) | -3.57M (+11.21%) | -3.21M (-2.73%) | -3.30M (+21.77%) | -2.71M | 210K (-60.38%) | 530K (+278.57%) | 140K | -10.00K (-50.00%) | -20.00K | - | - |
EBITDA | -3.66M (-36.68%) | -5.78M (+29.89%) | -4.45M (-14.26%) | -5.19M (+77.74%) | -2.92M (-58.11%) | -6.97M (+1836.11%) | -360.00K (-66.36%) | -1.07M (-67.48%) | -3.29M | 70K (-66.67%) | 210K (-60.38%) | 530K (+278.57%) | 140K | -10.00K (-50.00%) | -20.00K | - | - |
Other Income / Expenses | |||||||||||||||||
Interest Income | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K | - | 10K | - | - | 10K (-99.64%) | 2.78M | - | - | - | - | - | - | - |
Interest Expense | 30K (-92.68%) | 410K (+925.00%) | 40K (0.00%) | 40K (+100.00%) | 20K (-50.00%) | 40K (+300.00%) | 10K | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 20K (0.00%) | 20K (0.00%) | 20K (0.00%) | 20K | - | 10K | - | - | 10K (-99.64%) | 2.78M | - | - | - | - | - | - | - |
Other Non Operating Income | - | - | - | - | - | 1.41M | - | - | - | 2.78M | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||
Income Before Tax | -3.92M (-49.61%) | -7.78M (+73.27%) | -4.49M (-14.15%) | -5.23M (-54.08%) | -11.39M (+536.31%) | -1.79M (-48.86%) | -3.50M (+7.69%) | -3.25M (-3.27%) | -3.36M | 940K | - | - | - | - | - | - | - |
Income Tax Expense | -450.00K (-15.09%) | -530.00K (-58.91%) | -1.29M | - | - | -450.00K (+221.43%) | -140.00K (-85.57%) | -970.00K | - | 150K (+15.38%) | 130K (-43.48%) | 230K (+666.67%) | 30K | - | - | - | - |
Net Income From Continuing Operations | -3.47M (-52.14%) | -7.25M (+127.27%) | -3.19M (-39.01%) | -5.23M (-54.08%) | -11.39M (+463.86%) | -2.02M (+778.26%) | -230.00K (+130.00%) | -100.00K (+66.67%) | -60.00K (-33.33%) | -90.00K | 80K (-73.33%) | 300K (+172.73%) | 110K | -10.00K (-50.00%) | -20.00K | - | - |
Net Income | -3.47M (-52.14%) | -7.25M (+127.27%) | -3.19M (-39.01%) | -5.23M (-54.08%) | -11.39M (+463.86%) | -2.02M (+778.26%) | -230.00K (+130.00%) | -100.00K (+66.67%) | -60.00K (-33.33%) | -90.00K | 80K (-73.33%) | 300K (+172.73%) | 110K | -10.00K (-50.00%) | -20.00K | - | - |
Comprehensive Income Net Of Tax | -8.43M (-39.91%) | -14.03M (+286.50%) | -3.63M | 4.66M | -10.93M (+6.32%) | -10.28M (+205.95%) | -3.36M (+48.02%) | -2.27M (-32.04%) | -3.34M | - | - | - | - | - | - | - | - |